Daria Wineland, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1735 Orangewood Cir, Bartow, FL 33830 Phone: 863-534-1188 |
Mr. David William Drehs Ii, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2120 Marshall Edwards Dr, Bartow, FL 33830 Phone: 863-607-5948 |
Shreya Patel, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2055 E Georgia St, Bartow, FL 33830 Phone: 863-533-0578 |
Tender Touch Homecare And Companion Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2971 Morris Dr, Bartow, FL 33830 Phone: 404-449-4976 |
Kimberly Bagley, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 365 Lyle Pkwy, Bartow, FL 33830 Phone: 863-397-3315 |
Ruth Pannebaker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2055 E Georgia St, Bartow, FL 33830 Phone: 863-533-0578 |
News Archive
Aradigm Corporation today announced that it closed the transaction contemplated by the previously announced July 30, 2010 Stock Purchase Agreement with Novo Nordisk A/S. At the closing, the Company issued 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk A/S under which approximately $9.1 million was outstanding on July 30, 2010, representing an effective price per share of $0.3505.
The Washington Post examines access to maternal and child health services in Sierra Leone after the government dropped fees for such services last year, a move that "appears to have sharply cut into mortality rates for pregnant women and deaths from malaria for small children."
A new study from National Institutes of Health scientists and their Thai colleagues shows that a "good" bacterium commonly found in probiotic digestive supplements helps eliminate Staphylococcus aureus, a type of bacteria that can cause serious antibiotic-resistant infections.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
› Verified 4 days ago